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Abstract
Background. All previous histological studies of skele-
tal muscles of patients with renal failure have used
locomotor muscle biopsies. It is thus unclear to what
degree the observed abnormalities are due to the
uraemic state and how much is due to disuse. The
present study was undertaken to attempt to investigate
this question by examining a non-locomotor muscle
(rectus abdominis) in patients with end-stage renal
failure.
Methods. Biopsies from rectus abdominis were
obtained from 22 renal failure patients (RFPs) under-
going surgical Tenchkoff catheter implantation for
peritoneal dialysis and 20 control subjects undergoing
elective abdominal surgery. Histochemical staining of
frozen sections and morphometric analysis was used to
estimate the proportion of each ﬁbre type, muscle ﬁbre
area and capillary density. Myosin heavy chain com-
position was examined by SDS–PAGE.
Results. There were no differences in ﬁbre type
distribution between RFPs and controls. All RFPs
showed ﬁbre atrophy [mean cross-sectional area (CSA)
3300±1100 mm2, compared to 4100±1100 mm2 in
controls (P<0.05)]. All ﬁbre types were smaller in
mean CSA in RFPs than in controls (15, 26 and 28%
for types I, IIa and IIx, respectively). These differences
could not be accounted for by differences in age, gender
or cardiovascular or diabetic comorbidity. Muscle
ﬁbre capillarization, expressed as capillaries per ﬁbre
or capillary contacts per ﬁbre, was signiﬁcantly less in
RFPs.
Conclusions. Since a non-locomotor muscle was exam-
ined, the effects of disuse as a cause of atrophy have
been minimized. It is likely, therefore, that the
decreased muscle ﬁbre CSA and capillary density of
RFPs compared to controls were due predominantly to
uraemia itself.
Keywords: atrophy; non-locomotor muscle; renal
failure
Introduction
Muscle wasting and weakness are common in chronic
and end-stage renal failure and are associated with
physiological impairments and limitations in activities
of daily living [1]. An interrelated set of causal factors in
these circumstances includes decreased protein/calorie
intake, disuse atrophy and disordered muscle protein
balance that favours catabolism [2]. In addition,
anaemia and neuropathy (uraemic or diabetic) may
contribute to functional impairment [3].
All previous studies of skeletal muscle morphology in
renal failure have examined upper or lower limb (i.e.
locomotor) muscle biopsies [4–10]. It is possible that the
abnormalities observed may have been due both to the
effects of uraemia and to disuse atrophy. The purpose
of the present study, therefore, was to characterize
the degree of abnormality found in a non-locomotor
muscle of patients with renal failure, thereby largely
eliminating the potential inﬂuence of disuse atrophy.
It was hypothesized that the histochemical and mor-
phometric proﬁle of the renal failure muscle would be
abnormal in comparison with age-matched controls
free of renal failure.
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Subjects and methods
Patients
The renal failure patient (RFP) group consisted of 22 pre-
dialysis patients (12 women and 10 men), aged 54.7±14.3
(mean±SD) years. Patients who agreed to take part were
recruited sequentially. They had reached end-stage renal
failure (serum creatinine 6.4±2.1mg/dl, blood urea nitrogen
14.3±4.5mg/dl) and were studied at the time of catheter
insertion for peritoneal dialysis, just prior to the institution of
dialysis. The primary causes of renal failure were renovascular
disease in ﬁve cases, reﬂux nephropathy in four, diabetic
nephropathy in three, small kidneys of unknown cause in
three, glomerulonephritis in three, and amyloid in one.
Twelve patients had no comorbidity, eight had cardiovascular
comorbidity (ischaemic heart disease, peripheral vascular
disease, left ventricuslar dysfunction) and ﬁve were diabetic.
The nutritional status of the patients was assessed by the
subjective global assessment (SGA) method, using a seven-
point scale [11]. The SGA involved a careful history and
clinical examination. The accuracy, reproducibility and
validity of this method have previously been shown in dialysis
patients [12]. Blood samples were taken for measurement of
creatinine, albumin concentration, haemoglobin and para-
thyroid hormone.
The control (CON) group consisted of 20 subjects (10
women and 10 men), aged 58.5±16.9 (mean±SD) years,
undergoing elective abdominal surgery for various conditions
such as hernia repair and elective cholecystectomy, and none
had infective, malignant or inﬂammatory conditions. Blood
samples taken as a routine hospital procedure were analysed
for creatinine, albumin and haemoglobin.
All subjects were given both an oral and written
explanation of the purpose and procedures of the study
prior to participation and gave written informed consent.
All procedures were approved by the Local Research Ethics
Committee.
Muscle biopsy
A biopsy (200–500mg wet tissue) of rectus abdominis muscle
was obtained from each RFP undergoing Tenchkoff catheter
insertion for peritoneal dialysis [13] and from each control
subject undergoing abdominal surgery. The biopsy specimen
was kept moist on a piece of gauze that was moistened with
normal saline. The specimen was cut into two parts at right
angles in relation to the direction of muscle ﬁbres; one part
was used for histological and histochemical analysis and the
remainder for determination of myosin heavy chain (MyHC)
composition by gel electrophoresis.
Histological and histochemical analysis
The biopsy materials were rapidly frozen in isopentane
(155C) for 10 s and stored in liquid nitrogen (196C).
Serial sections of the samples were obtained by cutting
transverse sections of the biopsy (10 mm thickness in a cryostat
Leica CM1800, Germany) at 25C and collected on glass
slides treated with poly-L-lysine. All sections were stained on
the same day of cutting, with a time delay of 2 h.
Aminimum of three serial sections per patient were used for
histological examination; the morphological examination was
made using haematoxylin and eosin, Harris’s haematoxylin.
To determine the percentage of types I, IIa and IIx ﬁbres,
acid-labile myoﬁbrillar ATPase was used [14], with pre-
incubation at pH 4.40 and 4.75. For identifying the muscle
ﬁbre capillaries, an -amylase–PAS stain was employed [15].
The morphometric analysis was performed with a camera
(E.A.S.Y. 429K) connected to a light-microscope (Zeiss
axioskop) and digitizer (Mitsubishi, Video Copy Processor,
Herolab: molecular technique software) connected to a PC.
The cross-sectional area (CSA) of the muscle ﬁbres from each
sample was determined, the ﬁbre type distribution was deter-
mined from sections stained for myoﬁbrillar ATPase and the
number of ﬁbres per square millimetre was calculated from
the sections stained by the haematoxylin method. A minimum
number of 100 ﬁbres was studied from each sample. Morpho-
metric analysis was performed without prior knowledge of the
group origin of the biopsy. Atrophic ﬁbres were classiﬁed
as all those ﬁbres with a CSA of <50% of the control mean
CSA, which was speciﬁc for each ﬁbre type: 1729 mm2 for
type I, 2545mm2 for type IIa and 1749mm2 for type IIx.
Capillary proﬁle
Capillaries were quantiﬁed manually from photographs taken
from the previously described image analysis system. An area
containing at least 150 ﬁbres in each section was selected for
capillary counting. Analysis of capillary proﬁles included
the capillary-to-ﬁbre ratio (C:F), i.e. the ratio of the number
of capillaries occurring with 100 ﬁbres; capillary density per
square millimetre of muscle tissue (CD/mm2); and capillary
contact per ﬁbre (CC/F), i.e. the number of capillaries that
were adjacent to a single ﬁbre and thus used as a measure
of aerobic potential of skeletal muscle. All the capillary
measurements were determined from at least 100 ﬁbres,
except CD/mm2, which included all the ﬁbres within a
speciﬁed area (mm2). All transversely cut capillaries were
counted; if a capillary was sectioned longitudinally, it was
counted as one each time it crossed a junction between three
or more muscle ﬁbres.
MyHC analysis: one-dimensional gel electrophoresis
The proportion of MyHC isoforms present in the whole
muscle sample was determined as follows. Muscle specimens
(30–50mg) were homogenized (1mg of muscle tissue per 10ml
of buffer solution) in a buffer solution composed of 10%
glycerol (w/v), 5% 2-mercaptoethanol (w/v), 2.3% SDS (w/v),
62.5mM Tris and 0.001% bromophenol blue (w/v), pH 6.8
(corrected by HCl), and incubated at 80C for 10min.
Samples were then centrifuged at 12 000 g at 4C for 5min.
The supernatant fractions were collected and stored
separately (80C) and later analysed by SDS–PAGE.
Vertical PAGE (0.75mm thickness) in the presence of SDS
was performed according to the method of Talmadge andRoy
[16]. MyHCs were analysed in high-glycerol-containing gels
(30%). MyHC isoforms from the rectus abdominis muscle
were resolved into three separate bands, MyHC I and IIa and
IIx, in 8 and 4% polyacrylamide for separating and stacking
gels, respectively. The ratio of acrylamide and bisacrylamide
in stock was 50:1. The gels were run for 22 h at a constant
current of 20mA and at temperature of 4C. The relative
content of MyHC isoforms was determined by densitometry
using gels stained with Coomassie blue (R250). The protein
Non-locomotor muscle atrophy in renal failure 2075
 by guest on April 4, 2011
ndt.oxfordjournals.org
D
ow
nloaded from
 
bands were identiﬁed according to their apparent molecular
masses compared to the migration of high-molecular-weight
protein markers (C 3312, Sigma, Poole, UK). The densito-
metric system used Herolab software as described above, and
the coefﬁcient of variation of the gels analysis was 4.87%.
Statistical analysis
All analyses were carried out by using the statistical package
SPSS 9.0 for Windows (SPSS, Chicago, IL). Standard
descriptive statistics, consisting of means±SDs, were used
to characterize the subject population. 2 analyses were used
to assess percentage ﬁbre type and MyHC distribution
between the two groups. Two-way [group (CON and RFP) by
ﬁbre type (I, IIa and IIx)] mixed-model repeated measures
ANOVAs were used to examine differences in CSA. Tukey
HSD post hoc analysis was performed to indicate differences
within analyses. 2 analysis was used to compare the
percentage of atrophied types I, IIa and IIx ﬁbres between
the RFP and CON groups. Independent t-tests were used to
examine differences in mean ﬁbre CSA, CD/mm2, CC/F and
C:F between the two groups. An independent Student’s t-test
was performed to analyse the differences between malnour-
ished and well-nourished patients as well as the clinical
assessment data. An  level of P 0.05 was selected to
indicate statistical signiﬁcance.
Results
Haematological and biochemical evaluation
The RFP group showed signiﬁcantly higher serum
creatinine concentration (t40¼ 11.8, P<0.01) and
lower albumin (t40¼2.8, P<0.01) and haemoglobin
concentration (t40¼9.4, P<0.01) than the CON
group (Table 1).
Muscle ﬁbre type composition: histochemical analysis
In the rectus abdominis muscle of the CON group,
the dominant ﬁbre types were types I and IIa, which
together accounted for 88% of all ﬁbres present, and
12% of the ﬁbres were identiﬁed as type IIx (Table 2).
A similar pattern was found in the RFP group, in
which types I, IIa and IIx ﬁbres accounted for 49, 43
and 8%, respectively. 2 analyses indicated that no
signiﬁcant differences existed between the groups when
comparing the ﬁbre type distribution (P>0.05) or
percentage distribution of MyHC isoforms (P>0.05)
(Table 2).
MyHC isoform composition: SDS–PAGE
Similar to the histochemical analysis of ﬁbre type com-
position, the dominant MyHC isoforms were types I
and IIa, which accounted for 90% of the total MyHC in
both groups. 2 analysis revealed no statistically signiﬁ-
cant differences between the groups concerning the three
different types of MyHC isoforms (P>0.05) (Table 2).
Muscle ﬁbre CSA
Type I ﬁbres were revealed to be signiﬁcantly smaller in
CSA than type IIa ﬁbres (F2,39¼ 19.654,P<0.05). This
corresponded to a 32 and 22% smaller CSA for the
CON andRFP groups, respectively (Figure 1). Type IIx
ﬁbres, which accounted for 5–7%of all ﬁbres, also had a
smaller mean CSA compared to type IIa in both groups
(F2,39¼ 19.654, P<0.05) (Figure 1). All RFPs showed
a general muscle ﬁbre atrophy, and the mean CSA was
21% smaller (3300±1100 mm2) than in the CON group
(4100±1100 mm2, F1,43¼ 7.5, P<0.05); hence, the
number of ﬁbres per square millimetre of muscle was
higher (288±54 vs 254±78, F1,43¼ 2.069, P¼ 0.05)
in the RFP group than in the CON group. The ﬁbre
populationmost affected in the RFP group was the type
IIa ﬁbres, which were 26% smaller than in the CON
group (3800±1600 vs 5100±1500 mm2), and the
type IIx ﬁbre CSA was 28% smaller than in the CON
group (2500±1700 vs 3500±1200 mm2, F1,40¼ 7.5,
P<0.05) (Figure 1). Additional analysis of the renal
failure data demonstrated that those patients with some
form of comorbidity had smaller type I ﬁbres than those
with renal failure alone (2518±786 vs 2892±1120
mm2, P¼ 0.029). There were, however, no differences in
the size of the other types of muscle ﬁbres between RFPs
with and without some form of comorbidity or diabetes
(Table 5).
Nutritional status
The SGA showed that seven of the 22 RFPs were
malnourished (B or Bþ). No signiﬁcant differences in
Table 2. Fibre type distribution (%) and relative myosin heavy
chain (MyHC) content (%) in the renal failure patient (RFP,
n¼ 22) and control (CON, n¼ 20) groups based on histochemical
and SDS–PAGE analyses
RFP CON
Fibre type
Type I 49±9 50±14
Type IIa 43±11 38±14
Type IIx 8±8 12±12
MyHC content
MyHC I 48.6±11.9 47.3±14.9
MyHC IIa 40.6±14.1 42.6±14.5
MyHC IIx 10.8±13.2 10.1±10.9
Values are presented as means±SD.
Table 1. Haematological and biochemical variables in the renal
failure patient (RFP) and control (CON) groups
RFP CON
Creatinine (60–120mmol/l) 567±187a 92±25
Albumin (35–50 g/dl) 37±2a 42±6
Haemoglobin (13–18 g/dl) 10±1a 14±1
Mean venous TCO2 (24–32mmol/l) 22±3 –
Parathyroid hormone (6–20pmol/l) 19±13 –
aSigniﬁcant differences between groups (P<0.01).
TCO2, total bicarbonate.
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muscle ﬁbre CSA were observed between malnourished
and well-nourished patients (P>0.05).
Atrophy
Compared with the CON group, the muscle biopsies
of the rectus abdominis muscle from the RFP group
showed three times as many atrophied muscle ﬁbres
with random distribution in ﬁbre size and shape within
the muscle (Figure 2). In the CON group, only 10%
of all ﬁbres were classiﬁed as atrophic; in comparison,
in the RFP group, 27% of all ﬁbres have been
calculated as being atrophic (x2¼ 42.55, P<0.05)
(Table 3). In the type II ﬁbre populations of the RFP
group, 36% of the ﬁbres were atrophic. In the same
ﬁbre population of the CON group, the atrophy was
nearer to 12% (x2¼ 41.33, P<0.05). Atrophied ﬁbres
were found both in isolation and in small groups of
2–5 ﬁbres together; these were surrounded by rela-
tively normal-sized ﬁbres and occasionally adjacent
to unusually large hypertrophied ﬁbres (Figure 3).
Muscle ﬁbre capillarization
The CON group had 20% greater capillary density
than the RFP group when expressed as capillaries per
ﬁbre (t41¼5.7, P<0.05) but not when expressed as
CD/mm2 of muscle (P>0.05); as described above, this
difference is due to the higher number of ﬁbres per
square millimetre of muscle. The CON group also had a
greaterCC/F than theRFPgroup (t41¼3.8,P<0.05)
(Table 4).
Centronucleation
The nuclei of muscle ﬁbres are usually arranged around
the periphery of the ﬁbres; nucleii that are located
within the ﬁbre are usually indicative of a myopathy
or dystrophic process. The proportion of ﬁbres with
central located nuclei was 5±4% of the total ﬁbre
number in both groups.
Fig. 1. Fibre type cross-sectional area (CSA, mean±SD) for renal failure patients (open bars; n¼ 22) and controls (closed bars; n¼ 20).
Statistical signiﬁcant differences in ﬁbre size between groups were found for type IIa (**P<0.01) and IIx ﬁbres and mean CSA (*P<0.05).
Fig. 2. Photomicrograph of renal failure patient muscle biopsy,
showing muscle ﬁbre atrophy and random distribution in ﬁbre size
and shape.
Table 3. The percentage of atrophic ﬁbres in the renal failure
patient (RFP, n¼ 22) and control (CON, n¼ 20) groups
RFP CON
Total 27.0a 10.0
Type I 15.5 6.6
Type IIa 33.4a 12.3
Type IIx 46.8a 10.8
Type II 36.0a 12.0
The total percentage value represents the number of atrophic ﬁbres
in RFP and CON groups independent of ﬁbre type. The different
ﬁbre type percentage values represent the number of atrophic ﬁbres
within each speciﬁc ﬁbre type population.
aSigniﬁcant differences (P<0.05).
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Other histological abnormalities
The biopsies of RFPs sometimes showed clumping of
ﬁbre types and a loss of normal mosaic pattern of ﬁbre
type distribution (Figure 4).
Other abnormal features, such as large ﬁbres with
different shapes and clusters of ﬁbres undergoing
phagocytosis, were observed.
Discussion
This is the ﬁrst study of the morphology and
morphometry of rectus abdominis muscle biopsies in
pre-dialysis patients in end-stage renal failure. The only
other study of rectus abdominis in RFPs, by Conjard
et al. [17], did not include histological data. Muscle ﬁbre
type distribution and MyHC content in RFP biop-
sies were not different from control subjects and are
similar to those previously reported by Haggmark
and Thorstensson [18] for abdominal wall muscles of
normal control subjects. Patient samples showed sig-
niﬁcant generalized muscle ﬁbre atrophy, most marked
in types IIa and IIx ﬁbres (25–30% smaller than
controls), such that the number of ﬁbres per square
millimetre of muscle was greater in RFPs. Muscle ﬁbre
capillarization, expressed as capillaries per muscle
ﬁbre, was signiﬁcantly reduced compared to controls.
Additional abnormal histological features of note were
a wide range of ﬁbre sizes, ﬁbre type clumping and
some necrotic ﬁbres with associated inﬂammatory cell
inﬁltrate.
In the only published study of pre-dialysis patients,
Clyne et al. [1] found, as in the present study, gen-
eralized muscle ﬁbre atrophy with a greater degree of
atrophy in type II than in type I ﬁbres. In contrast,
though, they observed a greater proportion of type I
ﬁbres in the patients’ muscle. Since they studied biop-
sies of vastus lateralis, this discrepancy in ﬁbre type
distribution may be due to the confounding affect
associated with disuse atrophy, resulting from reduced
locomotory activity in the patients they studied. Most
other studies of skeletal muscle morphology in renal
failure have exclusively examined the locomotor muscle
group, the quadriceps, in haemodialysis patients [2,4–
10]. Common ﬁndings in these studies, as in the present
study, were of ﬁbre atrophy, mostly of type IIa ﬁbres,
variation in ﬁbre size and ﬁbre type grouping. Only two
other studies have investigated a semi-non-locomotor
muscle, the deltoid. Both were conducted in haemo-
dialysis patients, one in adults [9], one in children [10].
The deltoid may be considered to be intermediate
between rectus abdominis and quadriceps muscles in
terms of involvement in locomotion and therefore
subject to the effects of disuse atrophy. Nevertheless,
the ﬁndings in these two studies were broadly similar to
the present study, demonstrating type II ﬁbre atrophy,
ﬁbre size variation and ﬁbre type grouping. These
Fig. 3. Photomicrograph of renal failure patient muscle biopsy,
showing groups of atrophied ﬁbres surrounded by relatively normal-
sized ﬁbres.
Table 5. Muscle ﬁbre morphometry of the ﬁve renal failure patients whose comorbidity was diabetes
Type I Type IIa Type IIx Type I Type IIa Type IIx CD/mm2 CC/F C:F
(mm) (mm) (mm) (%) (%) (%)
3000 3700 1500 66 32 2 280 3.4 1.10
1800 1300 1100 35 59 6 400 2.7 1.14
1900 1900 1500 52 46 2 341 2.9 0.97
1500 3200 2100 48 47 5 451 3.3 1.32
2500 3400 3600 59 40 1 330 3.0 1.10
CD/mm2, capillary density per square millimetre of muscle tissue; CC/F, capillary contacts per muscle ﬁbre; C:F, capillary-to-ﬁbre ratio.
Table 4. Capillarization of muscle and the number of capillary
contacts per muscle ﬁbre and capillaries per muscle ﬁbre in the
renal failure patient (RFP) and control (CON) groups
Capillary factors RFP CON
CD/mm2 320±60 340±90
CC/F 3.0±0.4 4.0±0.5a
C:F 1.12±0.14 1.35±0.15a
CD/mm2, capillary density per square millimetre of muscle tissue;
CC/F, capillary contacts per muscle ﬁbre; C:F, capillary-to-ﬁbre
ratio.
aSigniﬁcant differences (P<0.01).
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similarities are, perhaps, all the more remarkable, since
the patients of Bautista et al. [9] were reported as
showing ‘proximal paresis’.
The likely systemic factors that may be associated
with ﬁbre atrophy in the RFPs in the present study
include metabolic acidosis, peripheral neuropathy,
malnutrition, anaemia or diabetic or cardiovascular
comorbidity. Since the controls and RFPs were
matched for age and gender, these potential inﬂuences
on muscle ﬁbre CSA cannot have accounted for the
differences between the groups. Acidosis has been
shown to be associated with increased muscle protein
catabolism in patients with chronic renal failure [19].
There are no published muscle biopsy studies of the
effects of acidosis correction in renal failure. Although
this intervention has been shown to decrease amino-
acid catabolism in chronic renal failure [20], neither of
the two clinical studies of acidosis correction in dialysis
patients was able to document an increase in muscle
mass or nutrition [21,22]. Our patients were mildly
acidotic, and therefore we cannot rule out a catabolic
effect from having a mild metabolic acidosis.
Peripheral neuropathy is associated with ﬁbre
atrophy and the changes in ﬁbre type grouping [23]
similar in pattern to that of other investigators and our
observations in RFP muscle. None of our patients
exhibited overt signs or symptoms of neuropathy. Our
ﬁndings may indicate, however, that sub-clinical
neuropathy is more widespread than is currently
appreciated. Fibre atrophy following denervation is,
like that associated with acidosis, mediated by the
ubiquitin/proteasome system, but no experimental
studies investigating the combined inﬂuence of a
combination of renal failure and denervation have
been published.
Malnutrition and starvation have been shown to be
associated with muscle ﬁbre wasting in a number of
clinical and experimental settings [7]. A decrease in
protein/calorie intake is known to occur early in the
progression of chronic renal failure, and malnutrition is
common in the pre-dialysis population. Fahal et al. [7]
found a signiﬁcant difference in ﬁbre CSA in quadri-
ceps biopsy samples between adequately nourished and
malnourished haemodialysis patients. In contrast, we
did not ﬁnd any differences in mean muscle CSA
between subjects categorized as adequately nourished
or malnourished, as deﬁned by the seven-point SGA
scale. They used a combination of plasma concentra-
tions of visceral proteins and the three-point SGA
grading as the means of measuring nutritional status.
Thus, their categorization of malnutrition was not the
same as ours. This, and any possible additional factors
contributed by the process of haemodialysis, may
explain the differences between the two sets of ﬁndings.
Since skeletal muscle represents the major store of body
protein, the degree of ﬁbre wasting in the present study
is potentially very important. It shows that up to about
one-ﬁfth loss of skeletal muscle contractile protein
may exist in pre-dialysis patients. Thus, the seven-
point SGA scale, a commonly used clinical nutrition
measurement tool, may underestimate the degree of
malnutrition in this patient population. It is possible
that the lower serum albumin level in the RFPs
compared with the controls was in part a reﬂection of
malnutrition.
It is possible that anaemia may have had a role in
determining ﬁbre atrophy. This proposal is based
on the ﬁndings of Davenport et al. [8], who found that
treatment of anaemia with erythropoeitin was asso-
ciated with an increase in muscle type I ﬁbre CSA in a
group of haemodialysis patients. Since the main abnor-
mality in the RFP biopsies related to type II ﬁbres,
it seems unlikely that anaemia was an inﬂuence. The
mechanism of their observations is not clear, although
increased oxygen delivery or increased physical activity
may be involved. In line with these observations, it has
been reported there is an increase in muscle strength
following erythropoeitin treatment [24].
Fig. 4. Photomicrographs of renal failure patient muscle biopsy, showing clusters of ﬁbres undergoing phagocytosis.
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Bed-rest and limb immobilization are associated with
marked muscle ﬁbre wasting in periods as short as 4
weeks, with type II ﬁbres being particularly affected,
together with a decrease in oxidative enzyme content
[25]. The appearances associated with bed-rest and
those seen in locomotor muscle biopsies in RFPs are,
therefore, quite similar. The fact that Kouidi et al. [2]
showed that ﬁbre atrophy was decreased following a
period of exercise training supports a proposal that
disuse contributes to this abnormality in locomotor
muscles in RFPs. Rectus abdominis is not directly a
locomotor muscle, although it has a role as a trunk
stabilizer during movement. It is unlikely, therefore,
that disuse atrophy is a signiﬁcant determinant of the
ﬁbre atrophy observed in our patient samples.
The ﬁnding that mean muscle ﬁbre CSA was not
different between those RFPs with and those without
cardiovascular or other comorbidity, and that no
differences in type II ﬁbre size was found, indicate that
these comorbidities are unlikely to have accounted for
the ﬁbre size reduction and atrophy in RFPs.
Our observation of decreased C:F ratio in RFPs is
novel. Disuse atrophy induced by bed-rest or limb
immobilization is associated with a decrease in capillary
density [26]. Moore et al. [6] observed a low C:F ratio in
quadriceps biopsy samples of haemodialysis patients,
which was not signiﬁcantly improved by the exercise
intervention they used. Bradley et al. [4] and Kouidi et
al. [2] reported muscle capillary abnormalities, seen on
electron microscopy, in haemodialysis patients. Kouidi
et al. [2] also reported an improvement in capillary
density following their exercise intervention trial, but
they did not provide any numerical data of capillary
density. It is likely, however, that physical activity
status explains some of the changes seen in lower limb
muscle biopsies in RFPs. As discussed above, this
inﬂuence is likely to be much less relevant in the
abdominal muscle investigated in the present study.
It may be of signiﬁcance that a similar defect in ﬁbre
capillarization has been observed in myocardial tissue
of dialysis patients [27]. It is possible that these ﬁnd-
ings and those of Bradley et al. [4], Moore et al. [6]
and Kouidi et al. [2], taken with ours, indicate that a
systemic defect of angiogenesis may exist in renal
failure.
The results of studies by previous workers suggest
that it is likely that disuse atrophy contributes to the
ﬁndings of degenerative changes in locomotor muscles
in RFPs. There are, however, many features common to
those we report in rectus abdominis, a muscle little
involved in locomotion. In addition, these features are
present in dialysis and in pre-dialysis patients.
We conclude that the state of renal failure itself
(‘uraemia’) plays an important role in the reduction of
the capillary density as well as the muscle size in pre-
dialysis patients. These abnormalities in skeletal muscle
of patients with end-stage renal disease have at least
two important implications: (i) an even greater degree
of malnutrition may exist in pre-dialysis patients than
is deﬁned by a commonly used clinical measure; and
(ii) exercise training interventions aimed at increasing
muscle bulk may need to be considered as a means
of improving not only physical function, but also
nutrition, in the renal failure population.
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